Valuation check: ATRC's profit margin is 1.85%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for ATRC is 1.85% as of June 2026. That compares with -7.27% in the prior-year period — up 125.5% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Atricure's historical trend and sector peers before judging valuation or financial health.
Over the past year, ATRC's profit margin moved from -7.27% to 1.85% — a 125.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Atricure's valuation or profitability profile.
Against Healthcare companies, ATRC currently prints 1.85% for profit margin, while the sector average sits near 13.89%. That is roughly 86.7% below the sector mean. Large gaps often invite a closer look at Atricure's growth, margins, and balance sheet.
Profit Margin shows how effectively Atricure converts resources into returns. At 1.85%, ATRC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -7.27% in the prior-year period — up 125.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ATRC's profit margin (1.85%), review year-over-year change from -7.27%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.